Evrofarma SA (EVROF.AT)
EUR 1.89
(0.53%)
EUR 1.89
(0.53%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 31.13 Million EUR | 3.44% |
| 2022 | 30.09 Million EUR | -11.26% |
| 2021 | 33.91 Million EUR | 18.57% |
| 2020 | 28.6 Million EUR | 18.68% |
| 2019 | 24.1 Million EUR | -10.65% |
| 2018 | 26.97 Million EUR | -5.5% |
| 2017 | 28.54 Million EUR | 3.88% |
| 2016 | 27.47 Million EUR | -3.11% |
| 2015 | 28.35 Million EUR | -10.26% |
| 2014 | 31.6 Million EUR | -14.54% |
| 2013 | 36.97 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 25.95 Million EUR | 0.0% |
| 2023 Q2 | 38.64 Million EUR | 0.0% |
| 2023 Q1 | 38.64 Million EUR | 11.08% |
| 2023 FY | 31.13 Million EUR | 3.44% |
| 2023 Q4 | 31.13 Million EUR | 0.0% |
| 2023 Q3 | 31.13 Million EUR | -19.44% |
| 2022 Q1 | 39.29 Million EUR | 15.87% |
| 2022 Q3 | 34.78 Million EUR | -11.48% |
| 2022 Q4 | 34.78 Million EUR | 0.0% |
| 2022 FY | 30.09 Million EUR | -11.26% |
| 2022 Q2 | 39.29 Million EUR | 0.0% |
| 2021 Q3 | 33.91 Million EUR | 11.57% |
| 2021 Q1 | 35.02 Million EUR | 22.47% |
| 2021 FY | 33.91 Million EUR | 18.57% |
| 2021 Q2 | 30.39 Million EUR | -13.22% |
| 2021 Q4 | 33.91 Million EUR | 0.0% |
| 2020 Q3 | 33.41 Million EUR | 32.79% |
| 2020 Q2 | 25.16 Million EUR | -16.72% |
| 2020 Q1 | 30.21 Million EUR | 25.37% |
| 2020 Q4 | 28.6 Million EUR | -14.4% |
| 2020 FY | 28.6 Million EUR | 18.68% |
| 2019 Q1 | 33.7 Million EUR | 3.47% |
| 2019 FY | 24.1 Million EUR | -10.65% |
| 2019 Q2 | 28.21 Million EUR | -16.29% |
| 2019 Q4 | 24.1 Million EUR | -17.83% |
| 2019 Q3 | 29.32 Million EUR | 3.95% |
| 2018 FY | 26.97 Million EUR | -5.5% |
| 2018 Q4 | 32.57 Million EUR | 0.0% |
| 2018 Q2 | 34.94 Million EUR | 0.0% |
| 2018 Q1 | 34.94 Million EUR | 1.69% |
| 2018 Q3 | 32.57 Million EUR | -6.79% |
| 2017 Q4 | 34.36 Million EUR | 0.0% |
| 2017 Q1 | 34.87 Million EUR | 3.94% |
| 2017 Q2 | 34.87 Million EUR | 0.0% |
| 2017 FY | 28.54 Million EUR | 3.88% |
| 2017 Q3 | 34.36 Million EUR | -1.45% |
| 2016 Q2 | 35.85 Million EUR | 0.0% |
| 2016 Q1 | 35.85 Million EUR | 3.76% |
| 2016 FY | 27.47 Million EUR | -3.11% |
| 2016 Q4 | 33.55 Million EUR | 0.0% |
| 2016 Q3 | 33.55 Million EUR | -6.42% |
| 2015 Q2 | 38.05 Million EUR | 2.68% |
| 2015 FY | 28.35 Million EUR | -10.26% |
| 2015 Q1 | 37.05 Million EUR | -2.49% |
| 2015 Q3 | 36.14 Million EUR | -5.0% |
| 2015 Q4 | 34.55 Million EUR | -4.41% |
| 2014 Q1 | 36.23 Million EUR | -2.0% |
| 2014 Q3 | 40.26 Million EUR | 4.82% |
| 2014 Q4 | 38 Million EUR | -5.61% |
| 2014 FY | 31.6 Million EUR | -14.54% |
| 2014 Q2 | 38.4 Million EUR | 5.99% |
| 2013 Q2 | 38.68 Million EUR | 2.54% |
| 2013 Q4 | 36.97 Million EUR | -6.74% |
| 2013 FY | 36.97 Million EUR | 0.0% |
| 2013 Q1 | 37.72 Million EUR | 0.0% |
| 2013 Q3 | 39.64 Million EUR | 2.5% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 37.23 Million EUR | 16.4% |
| Kri-Kri Milk Industry S.A. | 50.89 Million EUR | 38.834% |
| Loulis Food Ingredients S.A. | 98.69 Million EUR | 68.458% |